Venų klinika, MB - financials and debts

Company age: 4 y. 6 mo.

Update

Venų klinika - Company finances

EUR
2022
From: 2022-03-18
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 14,530 87,598 164,405
Profit before tax -325 1,509 7,141 13,244
Net profit -325 1,450 6,773 13,244
Equity -124 1,326 8,099 22,246
Liabilities 307 5,554 13,104 21,830
Non-current assets 0 2,470 6,836 21,297
Current assets 183 4,410 14,367 22,779
Total assets 183 6,880 21,203 44,076
Taxes paid
STI taxes - 211 6,689 19,293
Social insurance contributions - - 968 5,433
Financial indicators
Revenue change y/y - - +502.9% +87.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -177.6% 21.1% 31.9% 30.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 109.4% 83.6% 59.5%
Profit margin Net profit margin. Shows the overall profitability of the company. - 10.0% 7.7% 8.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - 10.4% 8.2% 8.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 4.2 1.6 1.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - 14,530 31,854 24,356

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Venų klinika - Social security debts

The company had no debts to Sodra

Venų klinika - VMI tax arrears

From To Overdue, €
2025-05-29 2025-06-04 13.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Venu klinika, MB (company code 306043207) is a Lithuanian small partnership providing intermediation service activities for medical, dental and other human health services. In 2025, the company generated revenue of EUR 164.4K and net profit of EUR 13.2K, with a profit margin of 8.1%. Revenue grew strongly from EUR 87.6K in 2024 and EUR 14.5K in 2023, showing a clear three-year expansion trend. Net profit also increased from EUR 1.4K in 2023 to EUR 6.8K in 2024 and EUR 13.2K in 2025. The latest year delivered revenue growth of 87.7% year on year and 1031.5% over two years. At the end of 2025, total assets amounted to EUR 44.1K, supported by equity of EUR 22.2K and liabilities of EUR 21.8K. Long-term assets stood at EUR 21.3K and short-term assets at EUR 22.8K. Key efficiency indicators were strong, with ROE at 59.5%, ROA at 30.1%, debt-to-equity at 0.98 and asset turnover at 3.73x. Revenue per employee was EUR 27.4K in 2025, indicating measurable operating productivity.